87 related articles for article (PubMed ID: 29335388)
1. Association between clinical stage of oral cancer and expression of immunohistochemical markers.
Świątkowski W; Rahnama M; Tomaszewski T; Bigas M; Świątkowska A; Łobacz M; Wallner J
Pol Przegl Chir; 2017 Dec; 89(6):17-22. PubMed ID: 29335388
[TBL] [Abstract][Full Text] [Related]
2. p53 and Ki-67 as predictive markers for radiosensitivity in squamous cell carcinoma of the oral cavity? an immunohistochemical and clinicopathologic study.
Koelbl O; Rosenwald A; Haberl M; Müller J; Reuther J; Flentje M
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):147-54. PubMed ID: 11163508
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53, epidermal growth factor receptor, c-erbB2 in oral leukoplakias and oral squamous cell carcinomas.
Singla S; Singla G; Zaheer S; Rawat DS; Mandal AK
J Cancer Res Ther; 2018; 14(2):388-393. PubMed ID: 29516925
[TBL] [Abstract][Full Text] [Related]
4. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
5. Combined Expression of c-jun, c-fos, and p53 Improves Estimation of Prognosis in Oral Squamous Cell Carcinoma.
Wang S; Xu X; Xu F; Meng Y; Sun C; Shi L; Zhao E
Cancer Invest; 2016 Sep; 34(8):393-400. PubMed ID: 27558649
[TBL] [Abstract][Full Text] [Related]
6. p53 In biopsies of oral squamous cell carcinoma. A comparative study with a malignancy grading system.
De Araújo VC; Loyola AM; Pinto Júnior DD; Borra RC; De Araújo NS
Oral Oncol; 1997 Jan; 33(1):5-9. PubMed ID: 9192545
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic molecular markers in oral and lip squamous cell carcinoma--evaluation of expression and its significance].
Jaworska M; Kołosza Z; Liszka J; Nikiel B; Goleń M; Lange D; Scierski W; Namysłowski G
Otolaryngol Pol; 2008; 62(2):175-81. PubMed ID: 18637442
[TBL] [Abstract][Full Text] [Related]
8. Quantitative cell-cycle protein expression in oral cancer assessed by computer-assisted system.
Soares CP; Zuanon JA; Teresa DB; Fregonezi PA; Neto CB; Oliveira MR; Donadi EA; Martinelli-Kläy CP; Soares EG
Histol Histopathol; 2006 Jul; 21(7):721-8. PubMed ID: 16598671
[TBL] [Abstract][Full Text] [Related]
9. Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus.
Soares CP; Benatti Neto C; Fregonezi PA; Teresa DB; Santos RT; Longatto Filho A; Maeda MY
Anal Quant Cytol Histol; 2003 Feb; 25(1):19-24. PubMed ID: 12630078
[TBL] [Abstract][Full Text] [Related]
10. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
11. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
12. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
[TBL] [Abstract][Full Text] [Related]
13. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.
Kondo Y; Yoshikawa K; Omura Y; Shinohara A; Kazaoka Y; Sano J; Mizuno Y; Yokoi T; Yamada S
Oncol Rep; 2011 May; 25(5):1227-33. PubMed ID: 21399882
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Expression of Podoplanin in Clinical Variants of Oral Leukoplakia and Its Correlation With Epithelial Dysplasia.
D'souza B; Nayak R; Kotrashetti VS
Appl Immunohistochem Mol Morphol; 2018 Feb; 26(2):132-139. PubMed ID: 27153448
[TBL] [Abstract][Full Text] [Related]
16. Evidence based demonstration of the concept of 'field cancerization' by p53 expression in mirror image biopsies of patients with oral squamous cell carcinoma - an immunohistochemical study.
Hande AH; Mohite DP; Chaudhary MS; Patel M; Agarwal P; Bohra S
Rom J Morphol Embryol; 2015; 56(3):1027-33. PubMed ID: 26662135
[TBL] [Abstract][Full Text] [Related]
17. Expression of metallothionein and p53 antigens are correlated in oral squamous cell carcinoma.
Cardoso SV; Silveira-Júnior JB; De Carvalho Machado V; De-Paula AM; Loyola AM; De Aguiar MC
Anticancer Res; 2009 Apr; 29(4):1189-93. PubMed ID: 19414363
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].
Zhao XY; Liu HW; Wei MJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):429-32. PubMed ID: 16086069
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of P57(kip2), p53 and hsp60 expressions in premalignant and malignant oral tissues.
Fan GK; Chen J; Ping F; Geng Y
Oral Oncol; 2006 Feb; 42(2):147-53. PubMed ID: 16246616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]